logo-loader
NASDAQ:MNMD NEO:MMED

MindMed

Receive alerts
Market:
NASDAQ
Price
-
Day Change
-
Market Cap:
-
52 weeks high
-
52 weeks low
-

In brief

MindMed is a clinical-stage psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including psilocybin, LSD, MDMA, DMT, mescaline and an Ibogaine derivative, 18-MC. The MindMed executive team brings extensive biopharmaceutical experience to MindMed’s approach to developing the next generation of psychedelic inspired medicines and therapies.